The State of the Art in Colorectal Cancer Molecular Biomarker Testing.
about
Current and future biomarkers in the treatment of colorectal cancer.Do More With Less: Tips and Techniques for Maximizing Small Biopsy and Cytology Specimens for Molecular and Ancillary Testing: The University of Colorado Experience.Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol.Clinical application of targeted next-generation sequencing for colorectal cancer patients: a multicentric Belgian experience.
P2860
The State of the Art in Colorectal Cancer Molecular Biomarker Testing.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The State of the Art in Colorectal Cancer Molecular Biomarker Testing.
@en
type
label
The State of the Art in Colorectal Cancer Molecular Biomarker Testing.
@en
prefLabel
The State of the Art in Colorectal Cancer Molecular Biomarker Testing.
@en
P2093
P2860
P1476
The State of the Art in Colorectal Cancer Molecular Biomarker Testing.
@en
P2093
Catherine E Lofton-Day
Deepti Dhall
Jean R Lopategui
Maha Guindi
Raju K Pillai
Scott D Patterson
Thomas Slavin
P2860
P304
P356
10.1097/PAP.0000000000000107
P577
2016-03-01T00:00:00Z